Drug combination found effective for Crohn's disease remissionA study led by Mayo Clinic recently suggested that a combination of immune-suppressing drugs first instead of immune-suppressing drugs alone may prove useful for bringing remission from Crohn’s disease.

It was found that a combination of infliximab plus azathioprine allows more patients to achieve mucosal healing and remission than a therapy with azathioprine alone.

William Sandborn, M.D., gastroenterologist and vice chair of the Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, said that these results are good enough to change clinical practice.

The study was published in the April 15, 2010 issue of the New England Journal of Medicine.